Loading organizations...
Loading organizations...
Biotech company developing drugs for neurological disorders.
Axoltis Pharma has raised $20.9M across 1 funding round.
Axoltis Pharma has raised $20.9M in total across 1 funding round.
Axoltis Pharma has raised $20.9M in total across 1 funding round.
Axoltis Pharma's investors include Frederic Picq, FIDAT Ventures, Agile Capital Market, Angelor, Daniel Oliver, Cercle de Chiron, Fa Diese, Fonds Régional Avenir Industrie Auvergne-Rhône-Alpes, Norfolk Green Ventures, Simba Santé, UI Investissement.
Axoltis Pharma has raised $20.9M across 1 funding round. Most recently, it raised $20.9M Series A in December 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 2, 2025 | $20.9M Series A | Frederic Picq, FIDAT Ventures | Agile Capital Market, Angelor, Daniel Oliver, Cercle de Chiron, Fa Diese, Fonds Régional Avenir Industrie Auvergne-Rhône-Alpes, Norfolk Green Ventures, Simba Santé, UI Investissement |